Bolt Biotherapeutics Inc
NASDAQ:BOLT
Income Statement
Earnings Waterfall
Bolt Biotherapeutics Inc
Income Statement
Bolt Biotherapeutics Inc
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||
| Revenue |
0
N/A
|
0
-29%
|
0
-23%
|
0
-70%
|
0
N/A
|
1
N/A
|
1
+68%
|
2
+64%
|
3
+67%
|
5
+39%
|
6
+19%
|
7
+18%
|
7
+1%
|
7
+6%
|
8
+9%
|
11
+44%
|
11
-1%
|
10
-12%
|
8
-21%
|
4
-53%
|
4
+15%
|
5
+25%
|
|
| Operating Income | |||||||||||||||||||||||
| Operating Expenses |
(37)
|
(42)
|
(49)
|
(59)
|
(72)
|
(83)
|
(94)
|
(100)
|
(101)
|
(101)
|
(96)
|
(92)
|
(88)
|
(85)
|
(84)
|
(86)
|
(85)
|
(82)
|
(76)
|
(67)
|
(58)
|
(50)
|
|
| Selling, General & Administrative |
(8)
|
(9)
|
(9)
|
(11)
|
(13)
|
(15)
|
(18)
|
(20)
|
(22)
|
(22)
|
(23)
|
(22)
|
(22)
|
(23)
|
(23)
|
(23)
|
(22)
|
(20)
|
(18)
|
(16)
|
(15)
|
(15)
|
|
| Research & Development |
(30)
|
(33)
|
(40)
|
(48)
|
(58)
|
(68)
|
(76)
|
(80)
|
(79)
|
(79)
|
(73)
|
(69)
|
(66)
|
(62)
|
(62)
|
(63)
|
(63)
|
(62)
|
(57)
|
(50)
|
(43)
|
(35)
|
|
| Operating Income |
(37)
N/A
|
(42)
-14%
|
(49)
-18%
|
(59)
-20%
|
(72)
-21%
|
(83)
-16%
|
(93)
-12%
|
(98)
-6%
|
(98)
+1%
|
(96)
+1%
|
(90)
+6%
|
(85)
+6%
|
(82)
+4%
|
(77)
+5%
|
(76)
+2%
|
(75)
+2%
|
(74)
+1%
|
(72)
+2%
|
(68)
+6%
|
(63)
+7%
|
(53)
+16%
|
(45)
+16%
|
|
| Pre-Tax Income | |||||||||||||||||||||||
| Interest Income Expense |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
5
|
6
|
7
|
7
|
7
|
6
|
5
|
5
|
4
|
3
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
1
|
1
|
(0)
|
(5)
|
(1)
|
(1)
|
|
| Total Other Income |
0
|
2
|
(12)
|
(18)
|
(18)
|
(20)
|
(6)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(36)
N/A
|
(39)
-8%
|
(61)
-56%
|
(77)
-26%
|
(89)
-16%
|
(102)
-15%
|
(99)
+4%
|
(98)
+1%
|
(97)
+1%
|
(95)
+2%
|
(88)
+8%
|
(81)
+8%
|
(77)
+6%
|
(71)
+7%
|
(69)
+3%
|
(63)
+9%
|
(66)
-5%
|
(65)
+2%
|
(63)
+3%
|
(63)
0%
|
(51)
+20%
|
(43)
+16%
|
|
| Net Income | |||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(36)
|
(39)
|
(61)
|
(77)
|
(89)
|
(102)
|
(99)
|
(98)
|
(97)
|
(95)
|
(88)
|
(81)
|
(77)
|
(71)
|
(69)
|
(63)
|
(66)
|
(65)
|
(63)
|
(63)
|
(51)
|
(43)
|
|
| Net Income (Common) |
(36)
N/A
|
(39)
-8%
|
(61)
-56%
|
(77)
-26%
|
(89)
-16%
|
(102)
-15%
|
(99)
+4%
|
(98)
+1%
|
(97)
+1%
|
(95)
+2%
|
(88)
+8%
|
(81)
+8%
|
(77)
+6%
|
(71)
+7%
|
(69)
+3%
|
(63)
+9%
|
(66)
-5%
|
(65)
+2%
|
(63)
+3%
|
(63)
0%
|
(51)
+20%
|
(43)
+16%
|
|
| EPS (Diluted) |
-20.98
N/A
|
-22.62
-8%
|
-33.43
-48%
|
-71.21
-113%
|
-48.68
+32%
|
-55.08
-13%
|
-52.72
+4%
|
-52.69
+0%
|
-51.96
+1%
|
-50.86
+2%
|
-47.16
+7%
|
-43.2
+8%
|
-40.68
+6%
|
-37.65
+7%
|
-36.6
+3%
|
-33.11
+10%
|
-34.7
-5%
|
-34.03
+2%
|
-33.06
+3%
|
-33.04
+0%
|
-26.44
+20%
|
-22.23
+16%
|
|